Article
p16 (CDKN2/cyclin-dependent kinase-4 inhibitor/multiple tumor suppressor-1) gene is not altered in uterine cervical carcinomas or cell lines.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Jan 1996
Hirama T, Miller C W, Wilczynski S P, Koeffler H P
Abstract excerpt
The p16 (CDKN2/cyclin-dependent kinase-4 inhibitor/multiple tumor suppressor-1) gene is frequently altered in cell lines and some types of cancers. To assess whether alterations of this gene are important in the pathogenesis of cervical cancer, we examined 41 primary tumors and 8 cell lines, usin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
